Cellular expression of Mcl-1, an anti-apoptotic Bcl-2 family member, is tightly regulated. Recently, Bcl-2 expression was shown to be regulated by
microRNAs, small endogenous
RNA molecules that regulate
protein expression through sequence-specific interaction with
messenger RNA. By analogy, we reasoned that Mcl-1 expression may also be regulated by
microRNAs. We chose human immortalized, but non-malignant, H69 cholangiocyte and malignant KMCH
cholangiocarcinoma cell lines for these studies, because Mcl-1 is dysregulated in cells with the malignant phenotype. By in silico analysis, we identified a putative target site in the Mcl-1
mRNA for the mir-29 family, and found that
mir-29b was highly expressed in cholangiocytes. Interestingly,
mir-29b was downregulated in malignant cells, consistent with Mcl-1
protein upregulation. Enforced
mir-29b expression reduced Mcl-1
protein expression in KMCH cells. This effect was direct, as
mir-29b negatively regulated the expression of an Mcl-1
3' untranslated region (UTR)-based reporter construct. Enforced
mir-29b expression reduced Mcl-1 cellular
protein levels and sensitized the
cancer cells to
tumor necrosis factor-related apoptosis-inducing
ligand (TRAIL) cytotoxicity. Transfection of non-malignant cells (that express high levels of mir-29) with a
locked-nucleic acid antagonist of
mir-29b increased Mcl-1 levels and reduced TRAIL-mediated apoptosis. Thus mir-29 is an endogenous regulator of Mcl-1
protein expression, and thereby, apoptosis.